Work Area: Patents

Latest content

Roivant Sciences

Featured in Special Report 2023 Q4: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Iprova

Featured in Special Report 2023 Q4: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Apollo Therapeutics

Featured in Special Report 2023 Q4: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Nimbus Therapeutics

Featured in Special Report 2023 Q4: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

The UPC and the unitary patent

Featured in Special Report 2023 Q4: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Meta

Featured in Special Report 2023 Q4: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

US patent eligibility reform bill hearing reveals deep dividing lines

Senators and witnesses before the US Senate Judiciary Committee's subcommittee on intellectual property called for Section 101 reform detractors to remove hurdles and propose improvements to the Patent Eligibility Reform Act of 2023

24 January 2024

Supreme People’s Court offers much-needed guidance following high-profile monopoly dispute involving pharma patents

In a 2023 landmark life sciences ruling, the Supreme People’s IP Court overturned the first-instance judgment – a decision that is having lasting effects on the Chinese IP landscape when it comes to assessing monopolies that involve patents.

24 January 2024

Specialist Chapter: Procuring Patent Protection for AI Inventions

Featured in The Patent Prosecution Review 2024

Obtaining patents for AI technologies presents unique challenges under the current legal framework in the United States, particularly when it comes to meeting Section 101 eligibility requirements, because AI technologies often involve software and mathematical algorithms. The uncertainty in the current state of Section 101 law is largely attributed to the two-step Alice framework. Mere distinctions from a human brain may not suffice for AI claims’ eligibility.

24 January 2024

BREAKING: Nokia and Oppo sign 5G patent cross-licence agreement

The long-awaited deal brings an end to over two years of litigation spanning India, China, Brazil, the UK and Germany

24 January 2024

Unlock unlimited access to all IAM content